Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Pfizer-Allergan deal: what next for contract manufacturers?

As CMOs wait to see the short-term fallout of the Pfizer-Allergan deal, an M&A expert says contract manufacturing will follow the CRO industry in embracing strategic alliances and consolidation.

Bigger in Japan: Biopta CEO predicts preclinical CRO business growth under new owners

Preclinical CRO Biopta will add stem cell programming tech to its offering, expand in Japan and nearly double its workforce under new owner, Reprocell.


Strategic CRO relationships no more effective than traditional models, Tufts

Inconsistent practices and a lack of trust are restricting sponsors from fully realising the potential of CRO strategic partnerships, according to Tufts' Director Kenneth Getz.

Xellia buys ex-Ben Venue site and aims to restart production in 2017

Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.

Eisai to sell clinical diagnostics supply business

Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).

Cyprotex: Predictive toxicology tech will help pharma cut animal study spending

Cyprotex has expanded its toxicology offering with a new in silico tech it claims will reduce preclinical costs and cut the number of animal studies required.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...